US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Veraxa Biotech AG

News headline image
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
From Veraxa Biotech AG
Via GlobeNewswire
Tickers VRXA
News headline image
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
From VERAXA Biotech AG
Via GlobeNewswire
Tickers VACH